|
|
||||||||
1 The Evans Memorial Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston 02118; 2 The Core Laboratory, Beth Israel Hospital and Deaconess Medical Center, Boston, Massachusetts 02115; 3 The Linus Pauling Institute, Oregon State University, Corvallis, Oregon 97331; and 4 Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
Ascorbate is a strong antioxidant;
however, it can also act as a prooxidant in vitro by reducing
transition metals. To investigate the in vivo relevance of this
prooxidant activity, we performed a study using guinea pigs fed high or
low ascorbate doses with or without prior loading with iron dextran.
Iron-loaded animals gained less weight and exhibited increased plasma
-N-acetyl-D-glucosaminidase activity, a
marker of tissue lysosomal membrane damage, compared with control
animals. The iron-loaded animals fed the low ascorbate dose had
decreased plasma
-tocopherol levels and increased plasma levels of
triglycerides and F2-isoprostanes, specific and sensitive markers of in vivo lipid peroxidation. In contrast, the two groups of
animals fed the high ascorbate dose had significantly lower hepatic
F2-isoprostane levels than the groups fed the low ascorbate dose, irrespective of iron load. These data indicate that 1)
ascorbate acts as an antioxidant toward lipids in vivo, even
in the presence of iron overload; 2) iron loading per se
does not cause oxidative lipid damage but is associated with growth
retardation and tissue damage, both of which are not affected by
vitamin C; and 3) the combination of iron loading with a low
ascorbate status causes additional pathophysiological changes, in
particular, increased plasma triglycerides.
antioxidant; ascorbate; F2-isoprostanes; guinea pigs; lipid peroxidation
This article has been cited by other articles:
![]() |
M.-C. Gomez-Cabrera, E. Domenech, M. Romagnoli, A. Arduini, C. Borras, F. V Pallardo, J. Sastre, and J. Vina Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance Am. J. Clinical Nutrition, January 1, 2008; 87(1): 142 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Chow and S.-J. Chang Value or Usefulness of the Food Frequency Questionnaire for the Assessment of Dietary Total Antioxidant Capacity J. Nutr., June 1, 2007; 137(6): 1496 - 1497. [Full Text] [PDF] |
||||
![]() |
N. Karasavvas, J. M. Carcamo, G. Stratis, and D. W. Golde Vitamin C protects HL60 and U266 cells from arsenic toxicity Blood, May 15, 2005; 105(10): 4004 - 4012. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Anderson, J. Hubacek, D. G. Wyse, and M. L. Knudtson Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudy J. Am. Coll. Cardiol., February 5, 2003; 41(3): 420 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Norwood Jr., A. D. Ledbetter, D. L. Doerfler, and G. E. Hatch Residual Oil Fly Ash Inhalation in Guinea Pigs: Influence of Absorbate and Glutathione Depletion Toxicol. Sci., May 1, 2001; 61(1): 144 - 153. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |